Skip to main content
Equibles

ACADIAN ASSET MANAGEMENT LLC

Position in STTK — Shattuck Labs, Inc.

CIK 916542 Boston, MA
Back to STTK Full portfolio

Position in STTK

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,685,948
+$507,677 QoQ
Shares Held
242,932
+32.6% QoQ
Ownership
0.242%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 100 holders
Holding Since
Mar 2022
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in STTK Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ACADIAN ASSET MANAGEMENT LLC holds $732,389,014 across 168 Biotechnology names. STTK ranks #51 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INCY
Incyte Corp
 1,664,999 $188,744,286
2 REGN
Regeneron Pharmaceuticals, Inc.
 157,440 $98,170,137
3 IMCR
Immunocore Holdings plc
 1,209,894 $38,414,134
4 RIGL
Rigel Pharmaceuticals Inc
 591,686 $23,146,756
5 EXEL
Exelixis, Inc.
 421,444 $22,930,768
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 42,122 $20,923,261
7 TBPH
Theravance Biopharma, Inc.
 1,174,910 $19,973,470
8 PRTA
Prothena Corp Public Ltd Co
 2,010,645 $19,684,214

All Filings in STTK

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,685,948 242,932
2026-03-31 $1,178,271 183,246
2025-12-31 $289,689 79,367
2025-09-30 $786,998 329,288
2025-06-30 $206,678 260,958
2025-03-31 $244,477 257,345
2024-12-31 $244,006 201,658
2024-09-30 $2,188 627
2024-06-30 $170,584 44,193
2022-03-31 $37,952 8,909